Earlier observations that acute administration of HCRT increases brain Aβ and that HCRT antagonism lessened amyloid plaque accumulation in a mouse model of AD (Kang et al., 2009) prompted assessment of the prevalence of AD in humans with narcolepsy. This evidence concerns the gene HCRT and amyloidosis.